Commentary Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/immunology.1.021
Targeting Mesothelin in Pancreatic Ductal Adeno- Carcinoma PDAC
Christopher Montemagno1,2,*, Gilles Pagès1,2
- 1Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco
- 2University Côte d’Azur, Institute for Research on Cancer and Aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, 06200 Nice, France
Corresponding Author
Christopher Montemagno, cmontemagno@centrescientifique.mc
Received Date: February 12, 2020
Accepted Date: March 02, 2020
Citation:
Montemagno C, Pagès G. Targeting Mesothelin in Pancreatic Ductal Adeno-Carcinoma (PDAC). J Cell Immunol. 2020; 2(2): 65-67.
Copyright: © 2020 Montemagno C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.